Thursday, 1 October 2026Updated 6m ago
← Top stories
Policy● Neutral for Indian equities

Karnataka flags 52x mark-up on cancer drugs, seeks Centre's intervention

1 source · first seen 12:57 1 Oct · updated 12:57 1 Oct

The brief

Written from 1 report · check the source before you trade
  • Karnataka inspections found cancer-drug mark-ups of up to 52 times and prompted a request for Centre intervention
  • Inspections revealed significant price disparities between hospital procurement and patient billing for cancer drugs and medical devices
  • Drug-pricing intervention could affect Indian pharmaceutical companies and hospital operators

Tags on this story

Pick a tag to see all its stories
Pharma and healthcare35 todayHospitals11 today

Linked by the tag Hospitals

47 stories this week
  1. 1 OctHospital stocks extend losses as drug-pricing regulation concerns linger; Apollo, Max among top Nifty losersMarket move · 1 source
  2. 1 OctHospital stocks sell-off a buying opportunity or a risk? Here is what analysts adviceMarket move · 1 source · The Supreme Court flagged a case where drugs costing 2,700 to retailers were billed at 27,000 to patients
  3. 1 OctCould Apollo, Fortis, Max Health Face A Profit Hit From Medicine Price Curbs? Jefferies, BofA, Macquarie Weigh InBroker call · 1 source · The Court questioned the spread between medicine purchase prices and MRP
  4. 30 SeptSupreme Court flags hospital cancer-drug markups; hospital stocks lose $2.6 billionLegal · 2 sources · The Supreme Court urged a probe into reports of steep cancer-drug markups by hospitals
  5. 30 SeptSC questions hospital drug mark-ups; hospital stocks fall up to 7%Market move · 4 sources · Apollo Hospitals, Fortis, KIMS and others fell up to 6% in one report and 7% in another
All Hospitals stories →

Read the reports

1 report · earliest 12:57
Economic TimesKarnataka flags 52x mark-up on cancer drugs, seeks Centre's intervention12:57